Janssen Can't Escape Bulk Of FCA Suit Over HIV Drug
A New Jersey federal judge ruled Wednesday that Janssen Products LP must face the bulk of claims in a False Claims Act lawsuit alleging the drugmaker unlawfully benefited from promoting off-label...To view the full article, register now.
Already a subscriber? Click here to view full article